BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3861004)

  • 1. Autoimmune mechanisms in inflammatory eye disease.
    Dumonde DC; Kasp-Grochowska E; Banga JP; Sanders MD; Graham E; Stanford MA; Faure JP; De Kozak Y; Van Tuyen V
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 3)():232-8. PubMed ID: 3861004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity and circulating immune complexes in retinal vasculitis.
    Kasp-Grochowska E; Graham E; Sanders MD; Dumonde DC; Kozak Y; van Tuyen V; Faure JP
    Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):342-8. PubMed ID: 6985101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity and the outer retina.
    Rahi AH; Addison DJ
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 4)():428-37. PubMed ID: 6611615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity and the retina.
    Faure JP
    Curr Top Eye Res; 1980; 2():215-302. PubMed ID: 7344837
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis.
    Romero MD; MuiƱo JC; Bianco GA; Ferrero M; Juarez CP; Luna JD; Rabinovich GA
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1550-6. PubMed ID: 16565391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy.
    Hooks JJ; Percopo C; Wang Y; Detrick B
    J Immunol; 1993 Sep; 151(6):3381-9. PubMed ID: 8397257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of uveal and retinal antigens in experimental autoimmune ocular pathology.
    Wacker WB; Kalsow CM
    Mod Probl Ophthalmol; 1976; 16():12-20. PubMed ID: 765778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.
    Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal autoimmunity: two decades of research.
    Wacker WB
    Jpn J Ophthalmol; 1987; 31(2):188-96. PubMed ID: 3312732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
    Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
    J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats.
    Ramanathan S; de Kozak Y; Saoudi A; Goureau O; Van der Meide PH; Druet P; Bellon B
    J Immunol; 1996 Sep; 157(5):2209-15. PubMed ID: 8757348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic expression of antibodies to retinal S-antigen in experimental autoimmune uveoretinitis.
    Suleyman S; Dumonde DC; Banga JP
    Immunology; 1987 Dec; 62(4):537-41. PubMed ID: 2448224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological aspects of spontaneous uveitis and retinopathy in HLA-A29 transgenic mice and in animal models of retinal autoimmunity: relevance to human pathologies.
    de Kozak Y; Camelo S; Pla M
    Ophthalmic Res; 2008; 40(3-4):175-80. PubMed ID: 18421235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.
    Robertson MJ; Erwig LP; Liversidge J; Forrester JV; Rees AJ; Dick AD
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2250-7. PubMed ID: 12091424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
    Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
    Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images.
    Xu H; Koch P; Chen M; Lau A; Reid DM; Forrester JV
    Exp Eye Res; 2008 Oct; 87(4):319-26. PubMed ID: 18634784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
    Kerr EC; Raveney BJ; Copland DA; Dick AD; Nicholson LB
    J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point prevalence study of 150 patients with idiopathic retinal vasculitis: 2. Clinical relevance of antiretinal autoimmunity and circulating immune complexes.
    Kasp E; Graham EM; Stanford MR; Sanders MD; Dumonde DC
    Br J Ophthalmol; 1989 Sep; 73(9):722-30. PubMed ID: 2804028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
    Greenwood J; Howes R; Lightman S
    Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.